ArticleAmerican journal of cancer research2023

A combination of BR101801 and venetoclax enhances antitumor effect in DLBCL cells via c-Myc/Bcl-2/Mcl-1 triple targeting.

Byeongwook Jeon et al.PubMed ↗Full text ↗

No numbers read from the abstract.